ClinicalTrials.Veeva

Menu

rTMS Treatment in Vascular Parkinsonism

I

Inje University

Status

Not yet enrolling

Conditions

Vascular Parkinsonism

Treatments

Device: Sham rTMS Supplementary motor area
Device: Real rTMS Supplementary motor area

Study type

Interventional

Funder types

Other

Identifiers

NCT03720691
18-0089

Details and patient eligibility

About

Vascular parkinsonism (VP), parkinsonism resulting from ischemic cerebrovascular disease, was suggested in 1929. The main features are wide-based gait, postural instability, and falls, which make patients with VP frustrated. Currently, the treatment is challenging.

Transcranial magnetic stiumation is a noninvasive procedure using electromagnetic induction to stimulate brain, and repetitive transcranial magnetic stiumation (rTMS) can selectively change brain activity to enhance desired effects. The aim of this study is to explore the therapeutic effect of rTMS for the VP.

Enrollment

32 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Vascular parkinsonism
  • age 18 and older

Exclusion criteria

  • pregnant or any, other medical, surgical, neurological or psychiatric conditions
  • other restrictions which prevent you from undergoing TMS recording, such as; surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), and/ or heart/cardiac lines
  • any past or current history of seizure disorder or epilepsy
  • unable to give informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

32 participants in 2 patient groups

Real rTMS Supplementary motor area
Active Comparator group
Description:
Real rTMS will be applied over the supplementary motor area
Treatment:
Device: Real rTMS Supplementary motor area
Sham rTMS Supplementary motor area
Sham Comparator group
Description:
Sham rTMS will be applied over the supplementary motor area
Treatment:
Device: Sham rTMS Supplementary motor area

Trial contacts and locations

1

Loading...

Central trial contact

Sang Jin Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems